Health ❯ Healthcare ❯ Medications

Weight Loss

Mounjaro GLP-1 Drugs GLP-1 Agonists GLP-1 Receptor Agonists GLP-1 Ozempic Orforglipron Wegovy Semaglutide Obesity Treatments

Wegovy Pill Fuels Massive Private Demand in UK as Supply Questions Grow

High preorders point to broader patient uptake with a real risk that manufacturing may not keep pace.

Samsung and MGH Launch Trial Using Galaxy Watch to Track Muscle Loss on GLP‑1 Therapy

Oral GLP‑1 Approval and New Trials Push Weight‑Loss Drugs Into Mass Market

UK Regulators Approve Single-Dose 7.2mg Wegovy Pen for Weekly Use

France’s Weight-Loss Drug Boom Spurs Shortages, Safety Alerts, and a Shadow Market

Doctor Warns GLP‑1 Weight‑Loss Shots Can Reduce Bone Density

Germany Keeps GLP-1 Weight-Loss Drugs Off Statutory Coverage

Stiftung Warentest Backs Only Mounjaro and Wegovy for Durable Weight Loss

GLP-1 Weight-Loss Boom Is Reshaping Diets as Experts Urge Lifestyle Support

Private GLP-1 Weight-Loss Use in UK Skews to Middle-Class Women, Analysis Shows

GLP‑1 Use Under Scrutiny After Study on Tolerability and Delhi OTC Sales

WHO-Backed Reviews Affirm GLP-1 Weight-Loss Gains as Clinicians Flag Safety and Nutrition Gaps

Trump Launches TrumpRx.gov With Discounts on More Than 40 Medicines, Including GLP-1 Drugs

The Beauty Debuts on FX, Hulu and Disney+ With Big Buzz and Divided Reviews

New Evidence Flags Rapid Weight Regain After Stopping GLP-1 Drugs

Liraglutide Patent Expiry Triggers Cheaper Weight‑Loss Generics in Germany

Wegovy Pill Posts Strong U.S. Debut as U.K. Authorizes Higher 7.2 mg Injectable Dose

FDA Seeks Removal of Suicide Warnings From Saxenda, Wegovy and Zepbound

Tom Brady Joins eMed as Founding Chief Wellness Officer and Board Member

States Curb Medicaid Coverage as First GLP‑1 Weight‑Loss Pill Debuts and Cash Prices Fall